MediSafe
-
StartUPDATES: New Developments from Healthcare Startups
Check out new developments from Medvantx, Medisafe, Medical Informatics Corp., Journey Biosciences, and GSR Ventures.
-
Could pharma, digital therapeutics partnerships be a $1B opportunity?
A panel discussion at the DTx East conference in Boston discussed whether partnerships between digital health and drugmakers were “a match made in heaven.”
-
Payer’s Place: Dr. Anil Singh
Dr. Anil Singh shares his insights into the strategies employed by the organization to identify the most effective digital solutions for their members.
-
What are the challenges and opportunities of running clinical trials of digital therapeutics?
Digital therapeutics clinical trials enable collection and analysis of data in real time, but considerations like standardization of analysis, trial endpoints and placebo controls are critical, experts at the DTx East conference in Boston said.
-
AmerisourceBergen’s Lash Group teams up with Medisafe to address patient adherence
Through their alliance, Medisafe will deliver real-time interventions to help patients stay adherent and will alert Lash Group’s clinicians when patients are considered “at-risk.”
-
Chronic disease management company Livongo boosts platform with new device and data capabilities
The new offerings are part of the company’s evolution to what it calls Applied Health Signals, a shorthand to describe their platform’s combination of data science and contextually relevant behavior change tools.
-
Discover the Next-Gen Platform for Integrated Collaborative Care
Beyond EHRs and digital front doors, reducing the gaps in patient care journeys.
-
Medisafe expands medication adherence research service for pharma and life science customers
The expanded service is designed to provide pharma companies with information that can help inform new strategies and tactics to improve patient engagement.
-
Medisafe raises $14.5M and adds London office to reflect growth in Europe
New European investor Octopus Ventures led the Series B round with participation from another new backer, M Ventures — the Amsterdam-based, strategic, corporate venture capital arm of Merck KGaA, in Darmstadt, Germany
-
When is medication adherence at its best (and worst)?
A Medisafe infographic illustrates how the digital health startup is using de-identified data to visualize when people are most and least likely to take their medication.
-
Pharma companies gain access to de-identified data on adherence for specific drugs
Medisafe’s new channel for pharma companies is aimed at helping drug developers better understand adherence dynamics and make it easier to tweak their guidance for patients and physicians.
-
Medisafe teams with Nestlé for pre-surgery nutrition reminders
In some ways, it’s a thinly veiled ad campaign for Nestlé’s pre-surgery nutrition drink, but it’s also a way to engage patients to help prevent surgical infections.
-
Medisafe-IMS Health study shows boost in adherence from digital health tool (infographic)
Study suggests the impact that digital health can have on chronic conditions.